New light has been thrown on how humans choose their partners, a scientist will tell the annual conference of the European Society of Human Genetics today (Monday May 25). Professor Maria da Graa Bicalho, head of the Immunogenetics and Histocompatibility Laboratory at the University of Parana, Brazil, says that her research had shown that people with diverse major histocompatibility complexes (MHCs) were more likely to choose each other as mates than those whose MHCs were similar, and that this was likely to be an evolutionary strategy to ensure healthy reproduction……..
Curcumin, the major polyphenol found in turmeric, appears to reduce weight gain in mice and suppress the growth of fat tissue in mice and cell models. Researchers studied mice fed high fat diets supplemented with curcumin and cell cultures incubated with curcumin.
An experimental vaccine applied the surface of the skin appears to protect against certain types of ear infections.
Treatment with surgery or an oral appliance that adjusts the jaw is associated with improvements in obstructive sleep apnea, a condition caused by blocked upper airways in which patients periodically stop breathing during sleep, according to two new reports.
A discovery offers new hope for the early diagnosis and treatment of Alzheimer’s disease. Scientists report that the addition of a single phosphate to an amino acid in a key brain protein is a principal cause of Alzheimer’s.
A pill used for nerve pain offers women relief from hot flashes, according to new research.
SAN FRANCISCO (MedPage Today) — Cardiovascular risk factors may be linked to lack of response to antidepressant treatment, researchers found.
The increased risk of persons with schizophrenia committing violent crime may be largely mediated by co-existing substance abuse problems, according to a new study.
SAN FRANCISCO (MedPage Today) — A patient’s personality may have as much to do with his satisfaction after knee replacement surgery as the clinical outcome, a small study shows.
SAN FRANCISCO (MedPage Today) — The antipsychotic drug loxapine, delivered with an investigational inhaler, quickly relieved acute agitation in patients with schizophrenia and bipolar disorder in separate phase III trials, researchers said.